These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28214915)

  • 1. Evaluation of the GARD assay in a blind Cosmetics Europe study.
    Johansson H; Gradin R; Forreryd A; Agemark M; Zeller K; Johansson A; Larne O; van Vliet E; Borrebaeck C; Lindstedt M
    ALTEX; 2017; 34(4):515-523. PubMed ID: 28214915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic allergen rapid detection in-house validation--a proof of concept.
    Johansson H; Rydnert F; Kühnl J; Schepky A; Borrebaeck C; Lindstedt M
    Toxicol Sci; 2014 Jun; 139(2):362-70. PubMed ID: 24675087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GARD platform for potency assessment of skin sensitizing chemicals.
    Zeller KS; Forreryd A; Lindberg T; Gradin R; Chawade A; Lindstedt M
    ALTEX; 2017; 34(4):539-559. PubMed ID: 29156079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From genome-wide arrays to tailor-made biomarker readout - Progress towards routine analysis of skin sensitizing chemicals with GARD.
    Forreryd A; Zeller KS; Lindberg T; Johansson H; Lindstedt M
    Toxicol In Vitro; 2016 Dec; 37():178-188. PubMed ID: 27638055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GARD assay for assessment of chemical skin sensitizers.
    Johansson H; Albrekt AS; Borrebaeck CA; Lindstedt M
    Toxicol In Vitro; 2013 Apr; 27(3):1163-9. PubMed ID: 23032079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARD.
    Forreryd A; Norinder U; Lindberg T; Lindstedt M
    Toxicol In Vitro; 2018 Apr; 48():179-187. PubMed ID: 29374571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitization.
    Forreryd A; Johansson H; Albrekt AS; Lindstedt M
    BMC Genomics; 2014 May; 15(1):379. PubMed ID: 24886304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the predictive nature of the Genomic Allergen Rapid Detection (GARD) assay with mammalian assays in determining the skin sensitisation potential of agrochemical active ingredients.
    Masinja W; Elliott C; Modi S; Enoch SJ; Cronin MTD; McInnes EF; Currie RA
    Toxicol In Vitro; 2021 Feb; 70():105017. PubMed ID: 33038465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.
    Albrekt AS; Johansson H; Börje A; Borrebaeck C; Lindstedt M
    BMC Pharmacol Toxicol; 2014 Feb; 15():5. PubMed ID: 24517095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GARDpotency Assay for Potency-Associated Subclassification of Chemical Skin Sensitizers-Rationale, Method Development, and Ring Trial Results of Predictive Performance and Reproducibility.
    Gradin R; Johansson A; Forreryd A; Aaltonen E; Jerre A; Larne O; Mattson U; Johansson H
    Toxicol Sci; 2020 Aug; 176(2):423-432. PubMed ID: 32421796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics.
    Frombach J; Sonnenburg A; Krapohl BD; Zuberbier T; Stahlmann R; Schreiner M
    Arch Toxicol; 2017 Jan; 91(1):339-350. PubMed ID: 27136899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly.
    Frombach J; Sonnenburg A; Krapohl BD; Zuberbier T; Peiser M; Stahlmann R; Schreiner M
    Arch Toxicol; 2018 Apr; 92(4):1495-1505. PubMed ID: 29380012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the GARD™skin Assay for Assessment of Chemical Skin Sensitizers: Ring Trial Results of Predictive Performance and Reproducibility.
    Johansson H; Gradin R; Johansson A; Adriaens E; Edwards A; Zuckerstätter V; Jerre A; Burleson F; Gehrke H; Roggen EL
    Toxicol Sci; 2019 Aug; 170(2):374-381. PubMed ID: 31099396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
    Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
    Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of skin sensitization potency using machine learning approaches.
    Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
    J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plasmacytoid dendritic cell (CD123+/CD11c-) based assay system to predict contact allergenicity of chemicals.
    Ayehunie S; Snell M; Child M; Klausner M
    Toxicology; 2009 Oct; 264(1-2):1-9. PubMed ID: 19665512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
    Forreryd A; Johansson H; Albrekt AS; Borrebaeck CA; Lindstedt M
    PLoS One; 2015; 10(3):e0118808. PubMed ID: 25760038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin sensitizers in cosmetics and beyond: potential multiple mechanisms of action and importance of T-cell assays for in vitro screening.
    Vukmanović S; Sadrieh N
    Crit Rev Toxicol; 2017 May; 47(5):415-432. PubMed ID: 28326907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT).
    Nukada Y; Ashikaga T; Sakaguchi H; Sono S; Mugita N; Hirota M; Miyazawa M; Ito Y; Sasa H; Nishiyama N
    Contact Dermatitis; 2011 Dec; 65(6):343-53. PubMed ID: 21767275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.